Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV 16 Infection”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Large-scale testing (Phase 3)WithdrawnNCT00733122
What this trial is testing

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06210854
What this trial is testing

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

Who this might be right for
HPV Infection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Early research (Phase 1)Ended earlyNCT01493154
What this trial is testing

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Not applicableActive Not RecruitingNCT05669911
What this trial is testing

Development of a Self-collection Device for Cervical Cancer Screening

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Human Papilloma Virus
Teal Health, Inc. 235
Testing effectiveness (Phase 2)Study completedNCT00316693
What this trial is testing

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,046
Testing effectiveness (Phase 2)Study completedNCT00091130
What this trial is testing

SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

Who this might be right for
Atypical Squamous Cells of Undetermined SignificanceCervical CancerHigh-grade Squamous Intraepithelial Lesion+1 more
National Cancer Institute (NCI) 139
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Large-scale testing (Phase 3)Study completedNCT00092495
What this trial is testing

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 3,055
Large-scale testing (Phase 3)Study completedNCT00929526
What this trial is testing

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 752
Large-scale testing (Phase 3)Looking for participantsNCT04422366
What this trial is testing

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 8,000
Large-scale testing (Phase 3)Study completedNCT00306241
What this trial is testing

Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Not applicableActive Not RecruitingNCT06243666
What this trial is testing

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerPersistent Infection
Xiamen University 2,188
Not applicableStudy completedNCT06919627
What this trial is testing

Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

Who this might be right for
Cervical CancersPapillomavirus InfectionsPapillomavirus Type 16/18 Infection
University Hospital, Brest 45
Not applicableUnknownNCT05587738
What this trial is testing

Human Papillomavirus in Young People Epidemiological Research 4

Who this might be right for
Human Papillomavirus InfectionHPVHPV Infection+4 more
Monash University 500
Testing effectiveness (Phase 2)Study completedNCT00365378
What this trial is testing

Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)

Who this might be right for
HPV 16 Infection
Merck Sharp & Dohme LLC 2,409
Testing effectiveness (Phase 2)Study completedNCT00551187
What this trial is testing

Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 620
Early research (Phase 1)Study completedNCT00635830
What this trial is testing

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 40
Load More Results